Minoan Group jumps as it signs exclusivity deal for sale of Travel & Leisure division
A look at some of the biggest risers and fallers in London on Tuesday
Company
EMV Capital
LON:NSCI
EMV Capital plc is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies. With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future, the group invests in, manages, and strengthens early stage IP-rich companies.
424 stories · page 14 of 22
NetScientific says portfolio company Vortex signs partnership deal with cell imaging firm BioView
The AIM-listed firm said the partnership will enable Vortex and Bioview to create integrated workflows that will allow the collection of intact circulating tumour cells (CTCs) from blood samples to become part of the standard of care
Archive
Proactive news snapshot: Scancell Holdings, Mosman Oil And Gas, InnovaDerma …
A glance at some of the day's highlights from the Proactive Investors newswire
LiDCO shares fall after saying it expects 2017 loss
A look at some of today's top risers and fallers in London today
NetScientific announces first sale of point-of-care test from portfolio company
The NEATstik test, registered with a CE mark in the second half of 2017, was sold to a research laboratory conducting a respiratory clinical trial for a pharmaceutical company
Investments and investor services
FTSE 100 closes up, boosted by mining stocks and as pound strengthens against the dollar
The UK's blue-chip index closes up 20.84 points to 7,234.81
Archive
Breakfast News -
Archive
Proactive news snapshot: Scancell, Bacanora Minerals, S & U …
A glance at some of the day's highlights from the Proactive Investors newswire
Ohhhh yes! Direct Line's trading update provides insurer with a lift
A look at some of the biggest risers and fallers in London on Friday
NetScientific highlights promising report on portfolio company Vortex BioSciences' cancer technology
The AIM listed transatlantic healthcare IP commercialisation group said the peer reviewed report, titled "Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer" describes the use of Vortex's tec
FTSE 100's losses lengthen as US markets move back into reverse
The US rally fizzled out prompting a late sell-off in an already below-water London
Archive
Proactive news snapshot: Instem, Thor Mining, Anglo Asian Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Speculators keep GKN shares higher, FTSE 100 miners under fire
A look at some of the top risers and fallers in London today
NetScientific hails progress of its portfolio companies in 2017
"We are encouraged by the first commercial sales of Vortex's VTX-1 Liquid Biopsy System and the continued expansion of ProAxsis' assay portfolio,” said Francois Martelet, the chief executive officer of NetScientific
Investments and investor services
FTSE 100 closes lower as miners prove a drag
London’s blue-chip benchmark closed around 13 points lower on the day at 7,755
Archive
Proactive news snapshot: MySQUAR, Live Company Group, Asiamet Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Soco shares rise as it confirms merger talks with Kuwait Energy
A look at some of the top risers and fallers in London today
NetScientific edges higher after portfolio company ProAxsis granted CE mark for its ProteaseTag
The award of the CE mark means the plasmin immunoassay conforms with various EU health, safety and environmental standards and is safe for sale within Europe
FTSE 100 closes in red as Wall Street comes off recent highs
London's top tier index closed down nearly 28 points at 7,696
Archive
Proactive news snapshot: Symphony Environmental Technologies, Futura Medical, LEKOIL …
A glance at some of the day's highlights from the Proactive Investors newswire